Gut Pathogens

Papers
(The TQCC of Gut Pathogens is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
A fatal case of Vibrio cholerae-associated diarrhea and bacteremia in a 30-year-old carrier of beta-thalassemia91
Clonal and horizontal transmission of carbapenem-resistant Enterobacterales strains and genes via flies58
A monoclonal antibody collection for C. difficile typing ?49
Significant abundance of bacterial flagellin and expression of its surface localized receptor toll-like receptor 5 and cytokine interleukin-22 in South African infants with poor oral rotavirus vaccine39
Dietary patterns drive loss of fiber-foraging species in the celiac disease patients gut microbiota compared to first-degree relatives39
Invasion of intestinal cells by Staphylococcus warneri, a member of the human gut microbiota38
Stunting is associated with persistent and transferable alterations in the gut microbiome32
Equol: a metabolite of gut microbiota with potential antitumor effects28
Assessing the impact of storage time on the stability of stool microbiota richness, diversity, and composition28
The emerging role of neutrophilic extracellular traps in intestinal disease28
Intestinal metabolites predict treatment resistance of patients with depression and anxiety27
A case–control study of the association between the gut microbiota and colorectal cancer: exploring the roles of diet, stress, and race27
Comparative genomic characterization of multidrug-resistant Citrobacter spp. strains in Fennec fox imported to China26
Translocating lipopolysaccharide correlates with the severity of enterovirus A71-induced HFMD by promoting pro-inflammation and viral IRES activity25
Profile of intestinal fungal microbiota in acute pancreatitis patients and healthy individuals25
Characteristics of ESBL-positive Klebsiella pneumoniae isolated from paired children with and without diarrhea24
The role of non-Helicobacter pylori bacteria in the pathogenesis of gastroduodenal diseases24
Elucidating antibiofilm as well as photocatalytic disinfection potential of green synthesized nanosilver against multi-drug-resistant bacteria and its photodegradation ability of cationic dyes24
Interaction between PSMD10 and GRP78 accelerates endoplasmic reticulum stress-mediated hepatic apoptosis induced by homocysteine24
Retrospective analysis of Clostridioides difficile and other intestinal infections in patients with Crohn’s disease and ulcerative colitis in the tertiary hospital in Poland. POLIBD survey results22
A prospective investigation into the association between the gut microbiome composition and cognitive performance among healthy young adults21
Fecal microbiome alterations of mice following immunization with gold nanoparticle vaccines against enterohemorrhagic Escherichia coli20
Impact of invasive infections on clinical outcomes in acute pancreatitis: early predictive factors and implications for prophylactic anti-infective therapy19
Tripartite interplay: immune reconstitution dynamics in AIDS, gut microbiota, and Helicobacter pylori infection: current advances and therapeutic prospects18
Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease18
Pathogenetic detection, retrospective and pathogenicity analysis of a fatal case of Vibrio vulnificus in Shenzhen, China17
Genomes of Vibrio metoecus co-isolated with Vibrio cholerae extend our understanding of differences between these closely related species17
A systematic review and meta-analysis of protozoan parasite infections among patients with mental health disorders: an overlooked phenomenon17
Helicobacter pylori infection: is there circulating vacuolating cytotoxin A or cytotoxin-associated gene A protein?16
Recent five-year progress in the impact of gut microbiota on vaccination and possible mechanisms16
Fecal glycoprotein 2 is a marker of gut microbiota dysbiosis and systemic inflammation16
Potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral load16
Genome insights of Enterococcus raffinosus CX012922, isolated from the feces of a Crohn’s disease patient15
Risk factors and clinical outcomes associated with multiple as opposed to single pathogens detected on the gastrointestinal disease polymerase chain reaction assay15
Antimicrobial growth promoters approved in food-producing animals in South Africa induce shiga toxin-converting bacteriophages from Escherichia coli O157:H7.15
16S rRNA sequencing analysis of the oral and fecal microbiota in colorectal cancer positives versus colorectal cancer negatives in Iranian population15
Dysbiosis of gut microbiota during fecal stream diversion in patients with colorectal cancer14
Tissue-specific transcriptomic adaptation in three strains of chickens during coinfections with parasites14
Prevalence of intestinal parasites and Helicobacter pylori coinfection, and contributing factors among patients with gastrointestinal manifestations at Addis Zemen primary hospital, Northwest Ethiopia14
Management of dyspepsia and Helicobacter pylori infection: the 2022 Indonesian Consensus Report13
The immune-adjunctive potential of recombinant LAB vector expressing murine IFNλ3 (MuIFNλ3) against Type A Influenza Virus (IAV) infection13
Overview of pathogenic Escherichia coli, with a focus on Shiga toxin-producing serotypes, global outbreaks (1982–2024) and food safety criteria13
A triad of gut dysbiosis, dysregulated immunity, and ‘leaky’ gut characterize HCMV associated neonatal cholestasis13
Metagenomics: a new frontier for routine pathology testing of gastrointestinal pathogens12
Etiology of diarrheal hospitalizations following rotavirus vaccine implementation and association of enteric pathogens with malnutrition among under-five children in India11
Bacteremia from streptococcus constellatus revealing a gastrointestinal stromal tumor11
The effects of probiotic treatment with Bifidobacterium breve, Bif195 for small intestinal Crohn’s disease and the gut microbiome: results from a randomised, double-blind, placebo-controlled trial11
Bacteroides- and Prevotella-enriched gut microbial clusters associate with metabolic risks11
Salmonella prevalence and serovar distribution in reptiles: a systematic review and meta-analysis11
Determinants of Campylobacter species diversity in infants and association with family members, livestock, and household environments in rural Eastern Ethiopia11
The use of biomarkers associated with leaky gut as a diagnostic tool for early intervention in autism spectrum disorder: a systematic review10
Genomic insights into zoonotic transmission and antimicrobial resistance in Campylobacter jejuni from farm to fork: a one health perspective10
Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial10
Comparison of antimicrobial resistant Escherichia coli isolated from Irish commercial pig farms with and without zinc oxide and antimicrobial usage10
Correction: Recent five-year progress in the impact of gut microbiota on vaccination and possible mechanisms10
Investigation and characterization of human gut phageome in advanced liver cirrhosis of defined etiologies10
High-dose dual therapy for Helicobacter pylori eradication inducing less impact on the gut microbiota10
Comparative genomics of Campylobacter jejuni from clinical campylobacteriosis stool specimens10
Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials9
Profiling of the tumor-associated microbiome in patients with hepatocellular carcinoma9
miR-125a-5p regulates the sialyltransferase ST3GAL1 in murine model of human intestinal campylobacteriosis9
Correlation between gut microbiota composition, enteric infections and linear growth impairment: a case–control study in childhood stunting in Pidie, Aceh, Indonesia9
Timing and clinical risk factors for early acquisition of gut pathogen colonization with multidrug resistant organisms in the intensive care unit9
Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection9
Epidemiological characteristics and genetic diversity of norovirus infections among outpatient children with diarrhea under 5 years of age in Beijing, China, 2011–20189
Dynamic changes in the gut microbiota composition during adalimumab therapy in patients with ulcerative colitis: implications for treatment response prediction and therapeutic targets9
Genetic evolution and phylogenetic analysis of porcine epidemic diarrhea virus strains circulating in and outside China with reference to a wild type virulent genotype CHYJ130330 reported from Guangdo9
Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients9
The gut microbiome, resistome, and mycobiome in preterm newborn infants and mouse pups: lack of lasting effects by antimicrobial therapy or probiotic prophylaxis9
Changes in the gut bacterial communities in colon cancer surgery patients: an observational study9
Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality8
Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection8
Risk factors for gut colonization with vancomycin-resistant enterococci among Bulgarian critically ill patients8
Gastrointestinal parasitic infections: Prevalence and risk factors in West Ismailia, Arab Republic of Egypt8
Detrimental relevance of Helicobacter pylori infection with sarcopenia8
Depletion of core microbiome forms the shared background against diverging dysbiosis patterns in Crohn’s disease and intestinal tuberculosis: insights from an integrated multi-cohort analysis8
Case report: Aberrant fecal microbiota composition of an infant diagnosed with prolonged intestinal botulism8
Correction: Molecular characterization and risk analysis of Giardia duodenalis assemblages in corticosteroid-treated and non-treated patients in Ismailia, Arab Republic of Egypt8
Elevated plasma and bile levels of corisin, a microbiota-derived proapoptotic peptide, in patients with severe acute cholangitis8
Gut microbiota profile in newly diagnosed pulmonary tuberculosis patients: an exploratory pilot study in southern India8
Clostridioides difficile toxin is infrequently detected in inflammatory bowel disease and does not associate with clinical outcomes8
Whole-genome sequencing analyses and antibiotic resistance situation of 48 Helicobacter pylori strains isolated in Zhejiang, China8
Development of the gut microbiota during early life in premature and term infants8
0.048049926757812